Chemours Co

The stock is entrenched in a Stage 4 decline within an overall uptrend, marked by a sustained series of lower highs and lows and the active Post-Parabola Collapse pattern. Price is extended below the 9/21 EMAs and hovering around the 200 DMA at extreme oversold levels without clear exhaustion signals. While the structural bias remains bearish, timing is unfavorable to add new shorts at these lows—deferred sell-on-rally entries into dynamic resistance zones is preferred.

• ↑TSS segment net sales +40% YoY; Option refrigerants grew 65%
• ↑Adjusted EBITDA margin reached 33%, reflecting strong pricing power
• ↓Leverage remains high despite $160 M net debt paydown, raising refinancing risk